IL6 and Miyoshi myopathy: OCs, in turn, also release several soluble factors (including IL6, CCL3, OPN, B-cell activating factor (BAFF), and a-proliferation-inducing ligand (APRIL)), which promote MM cell growth and survival, thus creating a vicious cycle between bone lesions and myeloma progression (see reviews [126,179]).